scorecardresearch
Add as a preferred source on Google
Tuesday, November 4, 2025
TopicAbbVie's Humira

Topic: AbbVie's Humira

Lucrative drugs like Viagra, Humira to lose patents but Indian pharma unlikely to gain

Indian pharma companies, which have dominated the world’s generic medicines market, are now hampered by Trump’s policies & lack of expertise in biologics.

Nobel 2018 for medicine & chemistry is great news for science, but probably not patients

The pharma industry needs to do a better job of grappling with how success tends to bring out its worst instincts.

On Camera

Govt shutdown, rate cut — US policy paralysis has created an opportunity for India

A depreciating dollar and abundant liquidity provide an opportunity to explore the rupee’s potential regional role. This represents a significant step toward monetary autonomy.

Nvidia worth $5 trillion: What does it mean for the market?

The chipmaker at the heart of the AI revolution may be the most influential stock in Wall Street history. Nvidia has been the primary driver of the market’s gains since the start of 2023.

Launch of India’s heaviest comms satellite is a level up for its soaring military ambitions. Here’s how

ISRO’s LMV3 rocket set off the CMS-03 satellite from Sriharikota Sunday. It weighs 4,410 kg, will primarily serve Indian Navy and has a life of at least 15 years.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.